Structural and immunogenicity analysis of chimeric B-cell epitope constructs derived from the gp46 and gp21 subunits of the envelope glycoproteins of HTLV-1

Journal of Peptide Research

Volumn 63, Issue 2, 2004, Pages 132-140

  Sundaram, R ^a   Beebe, M ^a   Kaumaya, P T P ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c Medical Research Facility   (United States)

Author keywords

B cell epitope; Immunogenicity; Neutralizing antibodies; Peptide

Indexed keywords

AMINO ACID; ANTIBODY; ENVELOPE PROTEIN; EPITOPE; GLYCOPROTEIN; GLYCOPROTEIN GP 21; GLYCOPROTEIN GP 46; PEPTIDE; PROTEIN SUBUNIT; TETANUS TOXOID; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANTIGEN STRUCTURE; ANTIGENICITY; ARTICLE; B LYMPHOCYTE; CHIMERA; CIRCULAR DICHROISM; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYSTAL STRUCTURE; EVALUATION; FEMALE; GENE CONSTRUCT; HELPER CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOGENICITY; MEASLES VIRUS; MOLECULAR MODEL; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RABBIT;

ANIMALS; CELL LINE, TUMOR; CIRCULAR DICHROISM; COMPUTER-AIDED DESIGN; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; GENE PRODUCTS, ENV; GIANT CELLS; HTLV-I ANTIBODIES; HTLV-I ANTIGENS; IMMUNIZATION; MICE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PEPTIDES; RABBITS; RATS; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE PROTEINS, ONCOGENIC; TETANUS TOXOID;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; MEASLES VIRUS; ORYCTOLAGUS CUNICULUS;

EID: 1542721102     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3011.2003.00113.x     Document Type: Article

References (38)

1. Poiesz, B.J., Ruscetti, F.W., Gazdar, A.F., Bunn, P.A., Minna, J.D. & Gallo, R.C. (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. U. S. A. 77, 7415-7419.
2. Nagy, K., Clapham, P., Cheingsong-Popov, R. & Weiss, R.A. (1983) Human T-cell leukemia virus type I: induction of syncytia and inhibition by patients' sera. Int. J. Cancer 32, 321-328.
3. Palker, T.J., Tanner, M.E., Scearce, R.M., Streilein, R.D., Clark, M.E. & Haynes, B.F. (1989) Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46. J. Immunol. 144, 971-978.
4. Baba, E., Nakamura, M., Tanaka, Y., Kuroki, M., Itoyama, Y., Nakano, S. & Niho, Y. (1993) Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine. J. Immunol. 151, 1013-1024.
5. Desgranges, C., Souche, S., Vernant, J.C., Smadja, D., Vahlne, A. & Horal, P. (1994) Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera. AIDS Res. Hum. Retroviruses 10, 163-173.
6. Grange, M.P., Rosenberg, A.R., Horal, P. & Desgranges, C. (1998) Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I). Int. J. Cancer 75, 804-813.
7. Kuroki, M., Nakamura, M., Itoyama, Y., Tanaka, Y., Shiraki, H., Baba, E., Esaki, T., Tatsumoto, T., Nagafuchi, S., Nakano, S. & Y-Niho. (1992) Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1. J. Immunol. 149, 940-948.
8. Inoue, Y., Kuroda, N., Shiraki, H., Sato, H. & Maeda, Y. (1992) Neutralizing activity of human antibodies against the structural protein of human T-cell lymphotropic virus type I. Int. J. Cancer 52, 877-880.
9. Tanaka, Y., Zeng, L., Shiraki, H., Shida, H. & Tozawa, H. (1991) Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization. J. Immunol. 147, 354-360.
10. Palker, T.J., Riggs, E.R., Spragion, D.E., Muir, A.J., Scearce, R.M., Randall, R.R., McAdams, M.W., McKnight, A., Clapham, P.R., Weiss, R.A. & Haynes, B.F. (1992) Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins. J. Virol. 66, 5879-5889.
11. Baba, E., Nakamura, M., Ohkuma, K., Kira, J., Tanaka, Y., Nakano, S. & Niho, Y. (1995) A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies. J. Immunol. 154, 399-412.
12. Tanaka, Y., Tanaka, R., Terada, E., Koyanagi, Y., Miyano-Kurosaki, N., Yamamoto, N., Baba, E., Nakamura, M. & Shida, H. (1994) Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization. J. Virol. 68, 6323-6331.
13. Copeland, T.D., Tsai, W.P., Kim, Y.D. & Oroszlan, S. (1986) Envelope proteins of human T cell leukemia virus type I: characterization by antisera to synthetic peptides and identification of a natural epitope. J. Immunol. 137, 2945-2951.
14. Horal, P., Hall, W.W., Svennerholm, B., Lycke, J., Jeansson, S., Rymo, L., Kaplan, M.H. & Vahlne, A. (1991) Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides. Proc. Natl. Acad. Sci. U. S. A. 88, 5754-5758.
15. Lairmore, M.D., Lal, R.B. & Kaumaya, P.T. (1995) Evaluation of immunodominant epitopes of human T-lymphotropic virus type 1 (HTLV-I) using synthetic peptides. Biomed. Pept. Proteins Nucleic Acids 1, 117-122.
16. Hadlock, K.G., Goh, C.J., Bradshaw, P.A., Perkins, S., Lo, J., Kaplan, J.E., Khabbaz, R. & Foung, S.K. (1995) Delineation of an immunodominant and human T-cell lymphotropic virus (HTLV)-specific epitope within the HTLV-I transmembrane glycoprotein. Blood 86, 1392-1399.
17. Sagara, Y., Inoue, Y., Shiraki, H., Jinno, A., Hoshino, H. & Maeda, Y. (1996) Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides. J. Virol. 70, 1564-1569.
18. Kaumaya, P.T.P., Feng, N., Kobs-Conrad, S., Seo, Y.H., Vanbuskirk, A.M. & Sheridan, J.F. (1992) Immunogenicity and antigenicity of a promiscuous T cell epitope and a topographic B cell determinant of the protein antigen LDH-C4. In: Peptides (Smith, J.A. & Rivier, J., eds), p. 883, Escom, Leiden.
19. Kaumaya, P.T.P., Seo, Y.H., Kobs, S., Feng, N., Sheridan, J. & Stevens, V. (1993) Peptide vaccines incorporating a 'promiscuous' T cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity. J. Mol. Recog. 6, 81-94.
20. Frangione-Beebe, M., Albrecht, B., Dakappagari, N., Rose, R.T., Brooks, C.L., Schwendeman, S.P., Lairmore, M.D. & Kaumaya, P.T. (2000) Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide [In Process Citation]. Vaccine 19, 1068-1081.
21. Lairmore, M.D., DiGeorge, A.M., Conrad, S.F., Trevino, A.V., Lal, R.B. & Kaumaya, P.T. (1995) Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction. J. Virol. 69, 6077-6089.
22. Kobs-Conrad, S., Lee, H., DiGeorge, A.M. & Kaumaya, P.T. (1993) Engineered topographic determinants with alpha beta, beta alpha beta, and beta alpha beta alpha topologies show high affinity binding to native protein antigen (lactate dehydrogenase-C4). J. Biol. Chem. 268, 25285-25295.
23. Kaumaya, P.T.P., Berndt, K., Heindorn, D., Trewhella, J., Kezd, F.J. & Goldberg, E. (1990) Synthesis and biophysical characterization of topographic immunogenic determinants with aa topologies. Biochemistry 29, 13-23.
24. Hudziak, R.M., Lewis, G.D., Winget, M., Fendly, B.M., Shepard, H.M. & Ullrich, A. (1989) p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol. Cell Biol. 9, 1165-1172.
25. Kaumaya, P.T.P., Kobs-Conrad, S., DiGeorge, A.M. & Stevens, V. (1994) De novo engineering of protein immunogenic and antigenic determinants. In: Peptides (Anantharamaiah, G.M. & Basava, C., eds), pp. 133-164. Springer-Verlag, New York.
26. Jinno, A., Haraguchi, Y., Shiraki, H. & Hoshino, H. (1999) Inhibition of cell-free human T-cell leukemia virus type 1 infection at a postbinding step by the synthetic peptide derived from an ectodomain of the gp21 transmembrane glycoprotein. J. Virol. 73, 9683-9689.
27. Kobe, B., Center, R.J., Kemp, B.E. & Poumbourios, P. (1999) Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins. Proc. Natl. Acad. Sci. U. S. A. 96, 4319-4324.
28. Kaumaya, P.T.P. (1996) Synthetic peptide vaccines: dream of reality. In: Peptides in Immunology (Schneider, C.H., ed.), pp. 117-148. Wiley and Sons, Ltd, UK.
29. Partidos, C.D., Salani, F.B., Ripley, J. & Steward, M.W. (1999) Deconstructing the antigenic profile of a protective epitope from measles virus fusion protein using overlapping peptides. Vaccine 18, 321-324.
30. Ho, P.C., Mutch, D.A., Winkel, K.D., Saul, A.J., Jones, G.L., Doran, T.J. & Rzepczyk, C.M. (1990) Identification of two promiscuous T cell epitopes from tetanus toxin. Eur. J. Immunol. 20, 477-483.
31. Panina-Bordignon, P., Tan, A., Termijtelen, A., Demotz, S., Corradin, G. & Lanzavecchia, A. (1989) Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 19, 2237-2242.
32. Kaumaya, P.T.P. (1994) A conceptual framework model of peptide vaccine engineering for eliciting humoral and cellular immune responses. In: Peptide Chemistry (Okada, Y., ed.), pp. 369-372. Protein Research Foundation, Osaka.
33. Jasanoff, A. & Fersht, A.R. (1994) Quantitative determination of helical propensities from trifluoroethanol titration curves. Biochemistry 33, 2129-2135.
34. Chou, P.Y. & Fasman, G.D. (1974) Prediction of protein conformation. Biochemistry 13, 222-245.
35. Collins, N.D., Newbound, G.C., Ratner, L. & Lairmore, M.D. (1996) In vitro CD4+ lymphocyte transformation and infection in a rabbit model with a molecular clone of human T-cell lymphotrophic virus type 1. J. Virol. 70, 7241-7246.
36. Maerz, A.L., Center, R.J., Kemp, B.E., Kobe, B. & Poumbourios, P. (2000) Functional implications of the human T-lymphotropic virus type 1 transmembrane glycoprotein helical hairpin structure. J. Virol. 74, 6614-6621.
37. Pinon, J.D., Kelly, S.M., Price, N.C., Flanagan, J.U. & Brighty, D.W. (2003) An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein. J. Virol. 77, 3281-3290.
38. Brighty, D.W. & Jassal, S.R. (2001) The synthetic peptide P-197 inhibits human T-cell leukemia virus type 1 envelope-mediated syncytium formation by a mechanism that is independent of Hsc70. J. Virol. 75, 10472-10478.